TO:Board of Health
MEETING DATE: November 7, 2018
REPORT NO.: BH.01.NOV0718.C21
PREPARED BY: Janice Walters, Manager, Control of Infectious Diseases, Jessica Morris, Manager, Rabies Program
APPROVED BY: Christopher Beveridge, Director, Health Protection
SUBMITTED BY: Dr. Nicola J. Mercer, MD, MBA, MPH, FRCPC Medical Officer of Health & CEO
MEETING DATE: November 7, 2018
REPORT NO.: BH.01.NOV0718.C21
PREPARED BY: Janice Walters, Manager, Control of Infectious Diseases, Jessica Morris, Manager, Rabies Program
APPROVED BY: Christopher Beveridge, Director, Health Protection
SUBMITTED BY: Dr. Nicola J. Mercer, MD, MBA, MPH, FRCPC Medical Officer of Health & CEO
Key Points
- Health Protection programs conduct annual inspections and disease follow-up.
- All compliance and complaint inspection reports are publically available on the Check Before You Choose website.
Strategic Directions & Goals
Service Centred Approach
- We are committed to providing excellent service to anyone interacting with public health.
Building Healthy Communities
- We will work with communities to support the health and well-being of everyone.
Operational Plan Objectives
- WDGPH will complete 100% annual compliance inspections.
- WDGPH will publicly disclose results of inspections (compliance and complaint).
- WDGPH will investigate complaints related to an inspected facility.
- WDGPH will mitigate health hazards and disease transmission based on risk.
Summary of OPHS Program Requirements
OPHS Program: Infectious Diseases Prevention and Control
Goals:
- To prevent or reduce the burden of infectious diseases of public health importance
Strategy:
- Disease Prevention/Health Protection
Requirements:
- To improve health and quality of life
- Reduced morbidity and mortality
Accountability Indicators:
| 2018 Infectious Diseases Indicators |
2018 Q3 July 1 – Sept 30 |
2018 Year to Date Jan 1- Sept 30 |
Comment |
|---|---|---|---|
| # and type of IPAC lapse by sector (PSS, dental office, community laboratories or independent health facility) |
0 | 3 | 1 Dental 2 OB/GYN |
| # and rate per 100,000 of new active TB infections annually |
N=2 Rate = 0.70/100,000 |
N=4 Rate = 1.41 /100,000 |
One case moved to Toronto after treatment started |
| # of cases of acquired drugresistance of active TB cases |
0 | 0 | None reported |
| # of cases of identified LTBI that are initiating prophylaxis and/or the number completing treatment (This is a new indicator reporting on people who started LTBI treatment in 2018) |
11 | 38 | |
| # of potential rabies exposures investigated annually |
243 | 608 | |
| # of animals investigated with current rabies vaccination (Animals investigated already vaccinated with Rabies vaccine at time of human exposure) |
80 | 225 | |
| # of persons given rabies postexposure prophylaxis |
28 | 59 |
Performance variance or discrepancy identified:
-
No
Highlights
No infection control lapses were found during infection control complaint investigations in the third quarter. WDGPH continues to provide education, training and resources to regulated health professionals on infection control best practices and reprocessing requirements.
The number of new Tuberculosis cases reported to date for 2018 is within the expected range.
Related Reports
- BH.01.SEP0518.C15 2018 Mid-Year Control of Infectious Diseases Program Performance Indicator Summary
- Rabies (Jan-Jun 2016) Program/Service Information Report
- BH.01.NOV0216.R19 Local and Provincial Raccoon Rabies Management Update
- BH.01.DEC0716.R21 Enactment of Legislation to Enforce Infection Prevention and
- Control Practices within Personal Service Settings under the HPPA
- BH.01.DEC0716.R22 Infection Control in Clinical Office Settings: A Regulated Health Professional Workshop
- BH.01.MAR0117.R08 Infection Prevention and Control Complaint
- BH.01.SEP0617.R23 Infection Control Lapse Dental Patient Recall
